Chilcott, J., McCabe, C., Tappenden, P., O'Hagan, A., Cooper, N. J., Abrams, K., & Claxton, K. (2003). Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ Group.
Citação norma ChicagoChilcott, Jim, Chris McCabe, Paul Tappenden, Anthony O'Hagan, Nicola J. Cooper, Keith Abrams, and Karl Claxton. Modelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Group, 2003.
MLA引文Chilcott, Jim, et al. Modelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Group, 2003.
警告:這些引文格式不一定是100%准確.